Arcus Biosciences Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Okay. I guess, good morning or good afternoon, depending on where you're situated in the world. Welcome to Barclays Global Healthcare Conference. I'm Peter Lawson. I'm one of the biotech analysts at Barclays. Just wanted to thank everyone for taking time out of the day today. (Operator Instructions) And it gives me great pleasure to introduce management team from Arcus today.
So we've got of course, Terry Rosen, CEO; Bill Grossman, CMO; Juan Jaen, the President of Research. And we've also got Kaytee Bock as well from IR. So thank you so much for joining us.
Questions & Answers
I guess I'll kick it off just with a general question I've been asking all our companies just like -- I guess, over 200, 300 oncology companies out there. What's your point of differentiation you think the company has -- that Arcus has that others perhaps don't have or try to imitate?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |